Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 17, 2020

SELL
$2.98 - $14.09 $60,345 - $285,322
-20,250 Closed
0 $0
Q4 2019

Jan 28, 2020

BUY
$1.97 - $3.72 $39,892 - $75,330
20,250 New
20,250 $70,000
Q4 2019

Jan 28, 2020

SELL
$1.97 - $3.72 $26,595 - $50,220
-13,500 Closed
0 $0
Q2 2019

Jul 17, 2019

BUY
$2.29 - $4.1 $30,915 - $55,349
13,500 New
13,500 $40,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $494M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Bay Colony Advisory Group, Inc D Portfolio

Follow Bay Colony Advisory Group, Inc D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

News

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.